QuintilesIMS Real-World Insights Bibliography

Risk of mortality and recurrent cardiovascular events in patients with acute coronary syndromes on high intensity statin treatment
Author(s): Rockberg J1, Jørgensen L1, Taylor B2, Sobocki P1, Johansson G3.
Affiliations(s): 1 QuintilesIMS, Solna, Sweden. 2 Amgen Inc, Thousand Oaks, CA, USA. 3 Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden.
Publication(s): Prev Med Rep
Document Type(s): Article
Countries: Sweden
Click here for the abstract
C:
Y:
Cardiovascular disease
2017
  L:
A:
English
Real World Evidence
  Add to report
 
 
The treatment of paroxysmal atrial fibrillation in UK primary care
Author(s): Andrea Isaew, Nicola Jaime Adderley, Ronan Ryan, David Fitzmaurice, Tom Marshall
Affiliations(s): University of Birmingham
Publication(s): 
Document Type(s): Article
Countries: UK
C:
Y:
Cardiovascular disease
2017
  L:
A:
English
Retrospective database analysis
  Add to report
 
 
CHARACTERIZATION OF STATIN EFFECTIVENESS USING REAL-WORLD DATA IN A CANADIAN POPULATION
Author(s): Shojaie S, McCurdy S, Thiele S, Ching Chau L, Martin L, Charland K, Dobson-Belaire W, Duclos M, Borrelli R
Affiliations(s): IMS Health Brogan., Mississauga, ON, Canada, IMS health Brogan, Kirkland, QC, Canada, IMS Health Brogan, Mississauga, ON, Canada
Publication(s): ISPOR 21st, May 2016, Washington, DC USA
Document Type(s): Poster
Countries: Canada
Click here for the abstract
C:
Y:
Cardiovascular disease
2016
  L:
A:
English
Retrospective database analysis
  Add to report
 
 
TREATMENT PATTERNS AMONG PATIENTS PRESCRIBED PDE-5 INHIBITOR MONOTHERAPY FOR PULMONARY HYPERTENSION
Author(s): Yeaw J, Lickert C, Drake W, De AP, Wade RL
Affiliations(s): 1IMS Health, San Francisco, CA, USA, 2Actelion Pharmaceuticals, Inc., South San Francisco, CA, USA, 3IMS Health, Plymouth Meeting, PA, USA
Publication(s): ISPOR 21th, May 2016, Washington DC USA
Document Type(s): Poster
Countries: USA
Click here for the abstract
C:
Y:
Cardiovascular disease
2016
  L:
A:
English
  Add to report
 
 
Lipid-lowering treatment patterns in patients with new cardiovascular events - estimates from population-based register data in Sweden.
Author(s): Hallberg S1, Banefelt J1, Fox KM2, Mesterton J1,3, Johansson G4, Levin LÅ5, Sobocki P3,6, Gandra SR7.
Affiliations(s): 1Quantify Research, Stockholm, Sweden. 2Strategic Healthcare Solutions, LLC, Baltimore, MD, USA. 3LIME/Medical Management Centre, Karolinska Institute, Stockholm, Sweden. 4Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden. 5Department of Medical and Health Sciences, Linköping University, Linköping, Sweden. 6IMS Health, Stockholm, Sweden. 7Amgen Inc., Thousand Oaks, CA, United States.
Publication(s): Int J Clin Pract
Document Type(s): Article
Countries: Sweden
Click here for the abstract
C:
Y:
Cardiovascular disease
2016
  L:
A:
English
Epidemiological study
  Add to report
 
 
Exposure to heart failure treatments in newly diagnosed patients in Sweden
Author(s): G Wikstrom1, K Boman2, M Olofsson2, K Lindmark3, R Lahoz4, S Corda4, V Wintzell5, R Linder5, A Gondos6, J Stalhammar7,
Affiliations(s): 1Uppsala University, Institute for Medical Sciences - Uppsala - Sweden, 2Umea University, Department of Public Health and Clinical Medicine - Umea - Sweden, 3Umea University, Heart Centre, Department of Public Health and Clinical Medicine - Umea - Sweden, 4Novartis Pharma AG - Basel - Switzerland, 5IMS Health Sweden - Stockholm - Sweden, 6IMS Health Germany - Berlin - Germany, 7Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden
Publication(s): European Journal of Heart Failure, 2016, Vol. 18, 48-48 p.
Document Type(s): Abstract
Countries: Sweden
Click here for the abstract
C:
Y:
Cardiovascular disease
2016
  L:
A:
English
Real World Evidence
  Add to report
 
 
Dosing of heart failure treatments in newly diagnosed unselected patients in Sweden: compliance with European society of cardiology guidelines
Author(s): G Wikstrom1, K Boman2, M Olofsson2, K Lindmark3, R Lahoz4, S Corda4, V Wintzell5, R Linder5, A Gondos6, J Stalhammar7
Affiliations(s): 1Uppsala University, Institute for Medical Sciences - Uppsala - Sweden, 2Umea University, Research Unit, Medicine and Geriatric, Skellefteå County Hospital, Department of Public Health - Umea - Sweden, 3Umea University, Heart Centre, Department of Public Health and Clinical Medicine - Umea - Sweden, 4Novartis Pharma AG - Basel - Switzerland, 5IMS Health Sweden - Stockholm - Sweden, 6IMS Health Germany - Berlin - Germany, 7Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden
Publication(s): European Journal of Heart Failure
Document Type(s): Abstract
Countries: Sweden
Click here for the abstract
C:
Y:
Cardiovascular disease
2016
  L:
A:
English
Real World Evidence
  Add to report
 
 
Recent trends in diagnostic work-up among unselected patients newly diagnosed with heart failure: a Swedish population-based study
Author(s): J Stalhammar1, K Boman2, M Olofsson2, K Lindmark3, R Lahoz4, S Corda4, V Wintzell5, R Linder5, A Gondos6, G Wikstrom7
Affiliations(s): 1Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden, 2Umea University, Research Unit, Medicine and Geriatric, Skellefteå County Hospital, Department of Public Health - Umea - Sweden, 3Umea University, Heart Centre, Department of Public Health and Clinical Medicine - Umea - Sweden, 4Novartis Pharma AG - Basel - Switzerland, 5IMS Health Sweden - Stockholm - Sweden, 6IMS Health Germany - Berlin - Germany, 7Uppsala University, Institute for Medical Sciences - Uppsala - Sweden
Publication(s): European Journal of Heart Failure
Document Type(s): Abstract
Countries: Sweden
Click here for the abstract
C:
Y:
Cardiovascular disease
2016
  L:
A:
English
Real World Evidence
  Add to report
 
 
A description of unselected patients with heart failure: a swedish population-based study
Author(s): J Stalhammar1, K Boman2, M Olofsson2, K Lindmark3, R Lahoz4, S Corda4, V Wintzell5, R Linder5, A Gondos6, G Wikstrom7
Affiliations(s): 1Uppsala University, Department of Public Health and Caring Sciences - Uppsala - Sweden, 2Umea University, Research Unit, Medicine and Geriatric, Skellefteå County Hospital, Department of Public Health - Umea - Sweden, 3Umea University, Heart Centre, Department of Public Health and Clinical Medicine - Umea - Sweden, 4Novartis Pharma AG - Basel - Switzerland, 5IMS Health Sweden - Stockholm - Sweden, 6IMS Health Germany - Berlin - Germany, 7Uppsala University, Institute for Medical Sciences - Uppsala - Sweden
Publication(s): European Journal of Heart Hailure
Document Type(s): Abstract
Countries: Sweden
Click here for the abstract
C:
Y:
Cardiovascular disease
2016
  L:
A:
English
Real World Evidence
  Add to report
 
 
Clinical Implications of Switching Lipid Lowering Treatment from Rosuvastatin to Other Agents in Primary Care.
Author(s): Colivicchi F1, Gulizia MM2, Franzini L3, Imperoli G4, Castello L1, Aiello A1, Ripellino C5, Cataldo N5.
Affiliations(s): 1 Cardiology Division, S. Filippo Neri Hospital, ASL Roma 1, Rome, Italy 2 Cardiology Division, Garibaldi Nesima Hospital,Catania, Italy 3 AstraZeneca S.p.A., Milan, Italy 4 Internal Medicine Division, S. Filippo Neri Hospital, ASL Roma 1, Rome, Italy 5 IMS Health Information Solutions Italy S.r.l., Milan, Italy
Publication(s): Advances in Therapy, 2016, [Epub ahead of print].
Document Type(s): Manuscript in preparation
Countries: Italy
Click here for the abstract
C:
Y:
Cardiovascular disease, Metabolic Disorders
2016
  L:
A:
English
Clinical setting: Primary care, Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis
  Add to report
 
 
 1 of 43 Next Page Last Page